Ultragenyx Pharmaceutical Inc. RARE
$26.49
+0.42%
at last close
Analyst Consensus
- Consensus Rating
- Buy (16 Buy · 2 Hold · 0 Sell)
- Average Price Target
- $56.50
- Implied Upside
- +113.3%
- Price Target Range
- $25.00 – $96.00
- Analysts (12 mo)
- 18
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-10 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $50 |
| 2026-08-05 | Wells FargoBenjamin Burnett |
Maintains | Overweight | $47 → $45 |
| 2026-08-04 | GuggenheimDebjit Chattopadhyay |
Maintains | Buy | $43 → $35 |
| 2026-07-07 | RBC CapitalLuca Issi |
Maintains | Outperform | $35 → $40 |
| 2026-05-21 | Cantor FitzgeraldKristen Kluska |
Maintains | Overweight | $84 → $96 |
| 2026-05-08 | WedbushLaura Chico |
Maintains | Neutral | $27 → $26 |
| 2026-05-08 | GuggenheimDebjit Chattopadhyay |
Maintains | Buy | $52 → $43 |
| 2026-05-06 | Wells FargoBenjamin Burnett |
Maintains | Overweight | $45 → $47 |
| 2026-05-06 | WedbushLaura Chico |
Maintains | Neutral | $27 → $26 |
| 2026-04-29 | BarclaysEliana Merle |
Maintains | Overweight | $44 → $43 |
| 2026-04-16 | Morgan StanleyJeffrey Hung |
Maintains | Overweight | $50 → $67 |
| 2026-03-24 | Goldman SachsSalveen Richter |
Downgrades | Buy → Neutral | $61 → $25 |
| 2026-03-12 | JP MorganAnupam Rama |
Maintains | Overweight | $120 → $74 |
| 2026-02-18 | Canaccord GenuityWhitney Ijem |
Maintains | Buy | $128 → $79 |
| 2026-02-18 | Evercore ISI GroupLiisa Bayko |
Maintains | Outperform | $37 → $34 |
| 2026-02-17 | Evercore ISI GroupLiisa Bayko |
Maintains | Outperform | $39 → $37 |
| 2026-02-17 | WedbushLaura Chico |
Reiterates | Neutral | $25 |
| 2026-02-17 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $60 → $50 |
| 2026-02-03 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $60 |
| 2026-01-05 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $80 → $60 |
| 2026-01-05 | GuggenheimDebjit Chattopadhyay |
Maintains | Buy | $64 → $52 |
| 2026-01-02 | B of A SecuritiesTazeen Ahmad |
Maintains | Buy | $72 → $58 |
| 2025-12-30 | Leerink PartnersJoseph Schwartz |
Maintains | Outperform | $80 → $70 |
| 2025-12-30 | BairdJoel Beatty |
Maintains | Outperform | $72 → $47 |
| 2025-12-30 | Wells FargoBenjamin Burnett |
Maintains | Overweight | $65 → $45 |
| 2025-12-30 | JefferiesMaury Raycroft |
Maintains | Buy | $114 → $63 |
| 2025-11-24 | BarclaysGena Wang |
Maintains | Overweight | $81 → $50 |
| 2025-11-05 | TD CowenYaron Werber |
Maintains | Buy | $86 → $75 |
| 2025-11-05 | Truist SecuritiesJoon Lee |
Maintains | Buy | $100 → $90 |
| 2025-09-09 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $80 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $26.49
- Market Cap
- $2.65 billion
- 52-Week Range
- $18.29 – $39.89
- Average Volume
- 1.95 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.